The French prospective study of Peyrade et al. [27], a multicentre, phase II, single arm trial with an attenuated R‐mini CHOP regimen in 150 elderly patients (> 80 years) with DLBCL showed for the first time that low serum albumin is associated with a shorter overall survival. This evidence concerns the gene ALB and diffuse large B-cell lymphoma.